Securian Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$840K Hold
4,443
0.03% 389
2025
Q4
$755K Sell
4,443
-100
-2% -$15.3K 0.03% 425
2025
Q3
$599K Sell
4,543
-151
-3% -$18.1K 0.02% 615
2025
Q2
$498K Buy
4,694
+124
+3% +$13.5K 0.01% 686
2025
Q1
$567K Hold
4,570
0.02% 619
2024
Q4
$563K Sell
4,570
-232
-5% -$27.3K 0.02% 643
2024
Q3
$535K Sell
4,802
-220
-4% -$24.1K 0.02% 668
2024
Q2
$536K Sell
5,022
-100
-2% -$11K 0.02% 649
2024
Q1
$617K Sell
5,122
-225
-4% -$27.6K 0.02% 621
2023
Q4
$658K Hold
5,347
0.02% 580
2023
Q3
$692K Sell
5,347
-334
-6% -$44.5K 0.02% 538
2023
Q2
$704K Sell
5,681
-100
-2% -$13.5K 0.02% 574
2023
Q1
$846K Hold
5,781
0.02% 508
2022
Q4
$921K Hold
5,781
0.03% 477
2022
Q3
$771K Buy
5,781
+100
+2% +$15.2K 0.02% 507
2022
Q2
$886K Buy
5,681
+158
+3% +$24.3K 0.02% 539
2022
Q1
$860K Hold
5,523
0.02% 588
2021
Q4
$704K Buy
5,523
+100
+2% +$13.1K 0.01% 665
2021
Q3
$706K Sell
5,423
-100
-2% -$15.1K 0.01% 641
2021
Q2
$981K Buy
5,523
+242
+5% +$41.9K 0.02% 569
2021
Q1
$868K Hold
5,281
0.02% 599
2020
Q4
$872K Sell
5,281
-105
-2% -$15.6K 0.02% 557
2020
Q3
$768K Buy
+5,386
New +$668K 0.02% 572

Other funds holding JAZZ

Securian Asset Management's JAZZ Position: Q1 2026 in Review

Securian Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 4,443 shares worth $840K. The position accounts for 0.03% of the portfolio, ranked #389.

Securian Asset Management first reported a position in JAZZ in Q3 2020 and has held it in 23 quarters since. The position peaked at $981K in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Securian Asset Management held 4,443 shares of Jazz Pharmaceuticals worth $840K as of Q1 2026.
  • Securian Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up 0.03% of Securian Asset Management's portfolio in Q1 2026, its #389 holding.
  • Securian Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Securian Asset Management's Jazz Pharmaceuticals position peaked at $981K in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.